Advertisement
Advertisement

AXGN

AXGN logo

Axogen, Inc. Common Stock

42.87
USD
Sponsored
+1.41
+3.40%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

42.94

+0.07
+0.16%

Axogen, Inc. Common Stock Profile

About

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Info & Links

CEO

Michael J. Dale

Headquarters

13631 PROGRESS BLVD.,SUITE 400
ALACHUA, FL 32615, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.axogeninc.com

Auditor

Deloitte & Touche LLP

Share holders

178

Employees

622

Axogen, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.28B

Enterprise Value

2.22B

Enterprise Value/EBITDA(ttm)

4.72K

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

7.61

Price to Book(mrq)

11.82

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

74.19%

Operating Margin(ttm)

-6.97%

Profit Margin(ttm)

-6.91%

Return on Equity(ttm)

-13.44%

Return on Invested Capital(ttm)

-8.31%

Return on Assets(ttm)

-7.48%

Income Statement

Revenue(ttm)

238.11M

Revenue Per Share(ttm)

4.48

Gross Profit(ttm)

178.61M

EBITDA(ttm)3

470.00K

Net Income Available to Common(ttm)

-31.45M

Diluted EPS(ttm)

-0.34

Share Statistics

Beta (5Y Monthly)

0.98

52-Week Change

292.58%

S&P 500 52-Week Change

22.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

53.18M

Dividend Yield

0.00%

Float4

50.45M

% Held by Insiders

2.78%

% Held by Institutions

80.29%

Balance Sheet

Total Cash(mrq)

103.60M

Total Cash Per Share(mrq)

1.95

Total Debt(mrq)

20.64M

Total Debt/Equity(mrq)

52.49%

Current Ratio(mrq)

5.11%

Quick Ratio(mrq)

3.31%

Book Value Per Share(mrq)

2.73

Cash Flow

Operating Cash Flow Per Share(ytd)

0.02

Free Cash Flow(ytd)

-2.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement